- Home
- APVO vs JTAI Comparison
APVO vs JTAI Comparison
Compare APVO & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- JTAI
- Stock Information
- Founded
- APVO 2016
- JTAI 2018
- Country
- APVO United States
- JTAI United States
- Employees
- APVO N/A
- JTAI N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- JTAI Blank Checks
- Sector
- APVO Health Care
- JTAI Finance
- Exchange
- APVO Nasdaq
- JTAI Nasdaq
- Market Cap
- APVO 6.5M
- JTAI 7.1M
- IPO Year
- APVO N/A
- JTAI N/A
- Fundamental
- Price
- APVO $4.46
- JTAI $3.86
- Analyst Decision
- APVO Strong Buy
- JTAI
- Analyst Count
- APVO 1
- JTAI 0
- Target Price
- APVO $296.00
- JTAI N/A
- AVG Volume (30 Days)
- APVO 90.6K
- JTAI 2.0M
- Earning Date
- APVO 03-04-2025
- JTAI 11-14-2024
- Dividend Yield
- APVO N/A
- JTAI N/A
- EPS Growth
- APVO N/A
- JTAI N/A
- EPS
- APVO N/A
- JTAI N/A
- Revenue
- APVO N/A
- JTAI $15,028,926.00
- Revenue This Year
- APVO N/A
- JTAI $21.49
- Revenue Next Year
- APVO N/A
- JTAI $10.05
- P/E Ratio
- APVO N/A
- JTAI N/A
- Revenue Growth
- APVO N/A
- JTAI 46.66
- 52 Week Low
- APVO $3.65
- JTAI $3.29
- 52 Week High
- APVO $399.60
- JTAI $324.00
- Technical
- Relative Strength Index (RSI)
- APVO 38.21
- JTAI 40.40
- Support Level
- APVO $4.32
- JTAI $3.42
- Resistance Level
- APVO $4.79
- JTAI $4.05
- Average True Range (ATR)
- APVO 0.45
- JTAI 0.51
- MACD
- APVO 0.15
- JTAI 0.11
- Stochastic Oscillator
- APVO 19.53
- JTAI 15.33
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.